Recall: D-0499-2026

Class II - Potentially Harmful

Class IIClassification

2026-04-20Initiated

OngoingStatus

SCOPE HEALTHFirm

Product

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.

Reason

Lack of Assurance of Sterility

Distribution

Nationwide within the United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.